Rating Change
JP Morgan analysts reiterated a Overweight rating on MetLife, Inc. (NYSE:MET) on July 21, 2026.
reiterateNYSE:MET
JP Morgan Reiterates Overweight Rating on MetLife, Inc. (MET)
Rating Change JP Morgan analysts reiterated a Overweight rating on MetLife, Inc. (NYSE:MET) on July 21, 2026. Market Context MetLife, Inc.
Market Context
MetLife, Inc. operates in the Financial Services sector. The stock currently trades at $93.37 with a market capitalization of $54.2B. The stock has gained 16.4% over the past 52 weeks.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for MetLife, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for MetLife, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 21, 2026 | JP Morgan | Overweight | N/A |
| Jul 13, 2026 | Evercore ISI Group | In-Line | N/A |
| Jul 13, 2026 | Keefe, Bruyette & Woods | Outperform | N/A |
| Jul 10, 2026 | Jefferies | Buy | N/A |
| Jul 09, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View MET Stock Page
Frequently Asked Questions
What does a Overweight rating mean for MET?
A Overweight rating from JP Morgan reflects the analyst's outlook on MetLife, Inc. (NYSE:MET). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MET forecast page.
